{
  "main_header": {
    "sid": 10039862,
    "name": "Sudeep Pharma",
    "stock_name": "Sudeep Pharma",
    "full_name": "Sudeep Pharma Ltd",
    "name_url": "stocks-analysis/sudeep-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,052.85",
    "chg": -59.05,
    "chgp": "-5.31%",
    "dir": -1,
    "prev_price": "1,111.90",
    "mcapval": "12,114.00 Cr",
    "mcap": "",
    "scripcode": 544619,
    "symbol": "SUDEEPPHRM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0QPI01025",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "5.68 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/sudeep-pharma-10039862-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 1,
    "sid": "10039862",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/sudeep-pharma-10039862"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "05-Oct-2026",
      "details": "We wish to inform the changes in the SMP of the Company arising due to completion of contractual arrangements between the company and Mr. Sendhil Pani Managing Director of Sudeep Pharma USA Inc. (Wholly Owned Subsidiary of Sudeep Pharma Limited) w.e.f. 2nd October 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Sep-2026",
      "details": "Intimation for Closure of Trading window w.e.f. 1st October 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "23-Sep-2026",
      "details": "This is to inform that the officials of the Company will be attending the Investor Conference organized by Nuvama Emerging India CEO Forum 2026 on 28th September 2026 at 10:00 a.m. in Mumbai.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sudeep Pharma Ltd has declared <strong>150%</strong> dividend, ex-date: 23 Jul 26",
          "dt": "2026-07-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News